Literature DB >> 20138939

RNA interference by nanofiber-based siRNA delivery system.

Haoqing Cao1, Xu Jiang, Chou Chai, Sing Yian Chew.   

Abstract

SiRNA delivery has found useful applications particularly as therapeutic agents against genetic diseases. Currently, the delivery of siRNA typically takes the form of nanoparticles. In order to expand the applications of these potent but labile molecules for long-term use required by tissue engineering and regenerative medicine, alternative delivery vehicles are required. This work presents a scaffold-mediated approach to siRNA delivery. By encapsulating siRNA within polycaprolactone (PCL) nanofibers (300-400nm in diameter) controlled release of intact siRNA could be achieved for at least 28days under physiological conditions. The successful transfection of HEK 293 cells with GAPDH siRNA released from fibrous scaffolds at day 5, 15 and 30 demonstrated that the encapsulated molecules remained bioactive throughout the period of sustained release, providing silencing efficiency of 61-81% that was comparable to conventional siRNA transfection. Direct seeding of cells on these biofunctional scaffolds, with and without transfection reagent, demonstrated enhanced cellular uptake and efficient GAPDH gene-silencing. This work demonstrates the potential of nanofibrous scaffold-mediated siRNA delivery for long-term gene-silencing applications. The combination of topographical features provided by nanofibrous scaffolds may provide synergistic contact guidance and biochemical signals to mediate and support cellular development in regenerative medicine. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138939     DOI: 10.1016/j.jconrel.2010.02.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  28 in total

1.  Directing neuronal differentiation of primary neural progenitor cells by gene knockdown approach.

Authors:  Wei Ching Low; Winifred Wing Yiu Yau; Lawrence W Stanton; Guillaume Marcy; Eyleen Goh; Sing Yian Chew
Journal:  DNA Cell Biol       Date:  2012-02-17       Impact factor: 3.311

Review 2.  Technologies for controlled, local delivery of siRNA.

Authors:  Samantha M Sarett; Christopher E Nelson; Craig L Duvall
Journal:  J Control Release       Date:  2015-11-28       Impact factor: 9.776

3.  Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.

Authors:  Paschalia M Mountziaris; David C Sing; Sue Anne Chew; Stephanie N Tzouanas; E Dennis Lehman; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

4.  RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects.

Authors:  Minh K Nguyen; Oju Jeon; Phuong N Dang; Cong T Huynh; Davood Varghai; Hooman Riazi; Alexandra McMillan; Samuel Herberg; Eben Alsberg
Journal:  Acta Biomater       Date:  2018-06-07       Impact factor: 8.947

Review 5.  Polymeric nanofibers in tissue engineering.

Authors:  Rebecca L Dahlin; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-07-28       Impact factor: 6.389

6.  Fabrication of electrospun zein nanofibers for the sustained delivery of siRNA.

Authors:  K Karthikeyan; Venkat Raghavan Krishnaswamy; Rachita Lakra; M S Kiran; Purna Sai Korrapati
Journal:  J Mater Sci Mater Med       Date:  2015-02-06       Impact factor: 3.896

Review 7.  Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.

Authors:  Leo L Wang; Jason A Burdick
Journal:  Adv Healthc Mater       Date:  2016-12-15       Impact factor: 9.933

8.  Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy.

Authors:  Sakib Iqbal; Mohammad H Rashid; Ali S Arbab; Mujibur Khan
Journal:  J Biomed Nanotechnol       Date:  2017-04       Impact factor: 4.099

9.  Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.

Authors:  Pim-on Rujitanaroj; Brian Jao; Junghoon Yang; Feng Wang; James M Anderson; Jun Wang; Sing Yian Chew
Journal:  Acta Biomater       Date:  2012-10-02       Impact factor: 8.947

10.  Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition.

Authors:  Eric N James; Anne M Delany; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.